The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $18.01 in the prior trading day, Annovis Bio Inc (NYSE: ANVS) closed at $7.28, down -59.58%. In other words, the price has decreased by -$59.58 from its previous closing price. On the day, 9.57 million shares were traded. ANVS stock price reached its highest trading level at $20.0 during the session, while it also had its lowest trading level at $5.23.
Ratios:
Our goal is to gain a better understanding of ANVS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.39 and its Current Ratio is at 2.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on December 29, 2023, initiated with a Buy rating and assigned the stock a target price of $36.
On July 07, 2021, Maxim Group reiterated its Buy rating and also lowered its target price recommendation from $45 to $150.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANVS now has a Market Capitalization of 198313760 and an Enterprise Value of 74407536.
Stock Price History:
The Beta on a monthly basis for ANVS is 1.46, which has changed by -0.47360808 over the last 52 weeks, in comparison to a change of 0.24191546 over the same period for the S&P500. Over the past 52 weeks, ANVS has reached a high of $22.49, while it has fallen to a 52-week low of $5.42. The 50-Day Moving Average of the stock is -31.44%, while the 200-Day Moving Average is calculated to be -31.95%.
Shares Statistics:
The stock has traded on average 239.99K shares per day over the past 3-months and 1293100 shares per day over the last 10 days, according to various share statistics. A total of 10.52M shares are outstanding, with a floating share count of 8.14M. Insiders hold about 26.05% of the company’s shares, while institutions hold 11.40% stake in the company. Shares short for ANVS as of 1713139200 were 1452712 with a Short Ratio of 6.05, compared to 1710460800 on 1347838. Therefore, it implies a Short% of Shares Outstanding of 1452712 and a Short% of Float of 17.4.
Earnings Estimates
A comprehensive evaluation of Annovis Bio Inc (ANVS) is underway, with the input of 2.0 analysts contributing to its current rating.On average, analysts expect EPS of -$0.69 for the current quarter, with a high estimate of -$0.59 and a low estimate of -$0.79, while EPS last year was -$1.19. The consensus estimate for the next quarter is -$0.45, with high estimates of -$0.35 and low estimates of -$0.55.
Analysts are recommending an EPS of between -$1.97 and -$2.16 for the fiscal current year, implying an average EPS of -$2.06. EPS for the following year is -$2.52, with 2.0 analysts recommending between -$2.22 and -$2.82.
